TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded without competition
Published 17 May 2021, 09:25 BST

Official UK procurement notice

Ixekizumab (Taltz®) · UK public procurement notice

Official notice

Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)

GoodsAward procedure without prior publication of a call for competition
Sectors: Medical Devices & Pharma (33) Delivery: Scotland (UKM)
Awarded value£2,943,000published contract · exc. VAT
Awarded 27 Apr 2021no call for competition
Awarded to Eli Lilly & Company Ltd

What is being bought

Published requirement description

Supply of Ixekizumab (Taltz®) to NHS Scotland.

CPV: Pharmaceutical products

The lotProcurement structure

single lot · no lot value published
Lot #1Supply of Ixekizumab (Taltz®) to NHS ScotlandAwarded

Supply of Ixekizumab (Taltz®) to NHS Scotland. The Authority has awarded this agreement as a single supplier agreement to one (1) supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
33600000 Pharmaceutical products

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Award procedure without prior publication of a call for competition
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
17 May 2021, 09:25 BST
Last source update
17 May 2021, 09:25 BST
Authority reference
AD50
FTS notice number
2021/S 000-010788
Classification (CPV)
Pharmaceutical products
Delivery area
Scotland (UKM)
Official registry OCID
ocds-h6vhtk-02b195 Find a Tender
Why no open competition

The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights

Published justification

Drug is patent protected for the duration of the agreement.

Review and risk notes
Review procedure

Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:

An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.

Publisher note: The estimated value(s) referred to in Section II.I.7 and section V.2.4 covers the twelve (12) month contract duration and the twelve (12) month extension period of the agreement. (SC Ref:653745)

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £2,943,0001 contract exc. VAT
Bids received 1
Contracts signed 1latest 27 Apr 2021
Awarded toValueDateStatus
Eli Lilly & Company Ltd£2,943,000 †—Awarded

Contracts

Bid statistics published by the authority

BidsSMEVCSEValid bid range
1bids · 0 electronic · 1 from abroad0——

Contracting authority & participating public bodies

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

Contracting authorityNHS & healthcareBody governed by public lawHealth Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, Scotland, EH12 9EBContact email, phone

Dispute resolution & review bodies

  • Edinburgh Sheriff CourtReview body Edinburgh

Bidders & participating suppliers

1 commercial party on the notice

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.